These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy.
    Author: Cunha-Vaz JG, Mota CC, Leite EC, Abreu JR, Ruas MA.
    Journal: Arch Ophthalmol; 1985 Sep; 103(9):1307-11. PubMed ID: 2931063.
    Abstract:
    To study the effect of sulindac on the alteration of the blood-retinal barrier, 24 insulin-dependent diabetic patients with minimal or no retinopathy were randomly assigned to receive either oral sulindac (200 mg twice daily) or a placebo for a period of six months. All patients underwent fundus photography, fluorescein angiography, and vitreous fluorophotometry before treatment and after 1, 3, and 6 months of treatment. Vitreous fluorophotometry data showed that there were fewer alterations of the blood-retinal barrier in the sulindac group compared with the placebo group during the six-month study period.
    [Abstract] [Full Text] [Related] [New Search]